Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[uniQure N.V.](/topic/$qure)

### Price: $XX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$qure/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$qure/time-series/close.tsv)  
The price action is likely driven by a combination of positive sentiment from recent clinical trial data, analyst recommendations, and overall market enthusiasm for gene therapy stocks. The stock has seen a significant increase over the last XX days, and the recent public offering and the potential for future partnerships are also contributing factors.  

| 24-Hour | 7-Day  | 30-Day  |
| ------- | -----  | ------  |
| -XXXX%  | -XXXX% | XXXXXX% |

**1-Year High**: $XXXXX on 2025-10-09  
**1-Year Low**: $XXXX on 2024-11-04

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

uniQure N.V.

Price: $XX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The price action is likely driven by a combination of positive sentiment from recent clinical trial data, analyst recommendations, and overall market enthusiasm for gene therapy stocks. The stock has seen a significant increase over the last XX days, and the recent public offering and the potential for future partnerships are also contributing factors.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% XXXXXX%

1-Year High: $XXXXX on 2025-10-09
1-Year Low: $XXXX on 2024-11-04

uniQure N.V. (QURE) Price
/topic/$qure/close